Cancer, the most deadly disease to human health, affects the lives of millions of people globally. Our team is trying to investigate the cause of medulloblastoma, the most common childhood cancer. Aggressive with a tendency to metastasize, medulloblastoma manifests as a range of neurological symptoms. Current therapies are encountering a number of obstacles. Our goal is to identify novel molecular and cellular mechanisms for the development of the most efficient strategies for medulloblastoma treatment.